Benzinga Pro's 5 Stocks To Watch Today

Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!

Casi Pharmaceuticals Inc CASI stock was trading higher by more than 40 percent early Thursday morning. The biopharmaceutical said it secured a strategic and long-term manufacturing agreement with China's Yiling Wanzhou for manufacturing of entecavir and cilostazo, two FDA approved products for the treatment of chronic hepatitis B viral and intermittent claudication

Stellar Biotechnologies Inc SBOT was trading higher by nearly 45 percent after announcing encouraging results from a research study focused on the molecular composition of the company's KLH products. The company said the "study results demonstrated highly consistent molecular structure from batch to batch, a key attribute for a biologically sourced protein."

Kroger Co KR gained more than 10 percent after the grocer reported its first-quarter results. The company said it earned 73 cents per share in the quarter on revenue of $37.53 billion versus expectations of 63 cents and $37.33 billion.

Micron Technology, Inc. MU was trading higher by nearly 4 percent after its fiscal third-quarter earnings beat was accompanied with a strong fiscal fourth-quarter outlook. Multiple research firms, including Stifel and Credit Suisse, turned incrementally bullish on the stock after the print.

Voyager Therapeutics Inc VYGR was trading higher by nearly 15 percent. The clinical-stage gene therapy company said the FDA granted a Regenerative Medicine Advanced Therapy (RMAT) designation for Voyager's VY-AADC gene therapy treatment for Parkinson's disease in patients with motor fluctuations

Related Links:

Benzinga's Daily Biotech Pulse: AbbVie Launches New Pediatric Humira, IPO Deluge Hits The Street

A Peek Into The Markets: US Stock Futures Fall Ahead Of Economic Reports